Clinical studies recruiting near Recife

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787 A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Phase 3 · Instituto de Medicina Integral Professor Fernando Figueira · Janssen Research & Development, LLC · NCT06449651 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-21001, Recife, Recife · Colorado Prevention Center · NCT06024746 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Real Hospital de Beneficência Portuguesa de Pernambuco · Pfizer · NCT06758401 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Hospital Agamenon Magalhaes · Amgen · NCT07037433 Effects of Trans-spinal Magnetic Stimulation on Cortical Excitability in Healthy Individuals
Phase 1 · Universidade Federal de Pernambuco · Universidade Federal de Pernambuco · NCT07026760 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · CEMER - Centro Médico do Recife · Eli Lilly and Company · NCT07369011 Effects of Peripheral Magnetic Stimulation on Cortical Excitability in Healthy Individuals
Phase 1 · Universidade Federal de Pernambuco · Universidade Federal de Pernambuco · NCT07025759 Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil
NA · Integral Medicine Institute Professor. Fernando Figueira-IMI · Instituto Materno Infantil Prof. Fernando Figueira · NCT06601582 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · IMIP Pernambuco · Boehringer Ingelheim · NCT06531824 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · Hospital das Clínicas da Universidade Federal de Pernambuco · Boehringer Ingelheim · NCT07220083 V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Phase 3 · IMIP Centro de Pesquisa · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06954441 Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT03955445 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · IMIP - Instituto de Medicina Integral Professor Fernando Fig · Daiichi Sankyo · NCT06731478 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-21021, Recife, Pernambuco · Colorado Prevention Center · NCT06033950 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
Phase N/A · Instituto de Medicina Integral Prof. Fernando Figueira (IMIP · Columbia University · NCT05929976 A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · Hospital das Clínicas da Universidade Federal de Pernambuco · Dimerix Bioscience Pty Ltd · NCT05183646 A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Phase 3 · Research Site · AstraZeneca · NCT06079671 Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer
Phase 3 · IMIP - Instituto de Medicina Integral Professor Fernando Fig · Latin American Cooperative Oncology Group · NCT04540692 Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
Phase N/A · Hospital Santa Joana Recife (Instituto Américas PE) · Latin American Cooperative Oncology Group · NCT06279442 Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Hospital de Câncer de Recife · Pfizer · NCT07222800 Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients
Phase 2 · Federal University of Pernambuco · Universidade Federal de Pernambuco · NCT07073287 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Hospital do Cancer de Pernambuco - HCP · Hoffmann-La Roche · NCT05894239 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 1531 · Anthos Therapeutics, Inc. · NCT05712200 V-IMMUNE® for Immune Thrombocytopenia
Phase 3 · IMIP Instituto de Medicina Integral Professor Fernando Figue · On Pharma Importadora, Exportadora e Distribuidora de Medica · NCT06962631 A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
Phase 2 · Hospital do Cancer de Pernambuco - HCP · Hoffmann-La Roche · NCT07054190

Look up another city

Look up another condition